Neal Curran is currently the Senior Vice President at Merz Therapeutics, overseeing Global Business Strategy and Portfolio Innovation. Prior to this role, Neal held various leadership positions at GSK, including Vice President Human Genetics BD and Interim Vice President Pipeline BD. With a background in business development and risk consulting, Neal has also worked at Grant Thornton LLP and Arthur Andersen Business Consulting. Neal holds a Master of Science in Accountancy and a Bachelor of Science degree from the University of North Carolina Wilmington.
November, 2023 - present